To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C15orf42TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
79 supporting clones for gene C15orf42 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_152259.3   .a 1 to 6667 1 to 6667 exact RefSeq, AAA   6667/6667
(100 %)
0 diff
(100 %id)
TI_891526345   .a 376 to 1078 1 to 696   tiling clone, fully sequenced,   696/696
(100 %)
10 diff
(98.6 %id)
DR731357 pooled .a 399 to 1100 1 to 702   tiling clone,   702/702
(100 %)
4 diff
(99.5 %id)
DR731358 pooled .a 1009 to 1726 717 to 1     Submitted on the opposite strand 717/718
(99 %)
2 diff
(99.8 %id)
TI_891526344   .a 1048 to 1740 694 to 9   tiling clone, fully sequenced,   686/694
(98 %)
0 diff
(100 %id)
BU184425 eye, retinoblastoma .a 1194 to 1905 1 to 721       721/932
(77 %)
18 diff
(98.1 %id)
DY654828 pooled .a 1499 to 1939 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
TI_1210517668   .a 1518 to 1986 1 to 469       469/471
(99 %)
9 diff
(98.1 %id)
DY654827 pooled .a 1541 to 1973 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
CN285632 embryonic stem cells, cell lines H1, H7, andH9 .a 1709 to 2404 1 to 697   tiling clone,   697/697
(100 %)
2 diff
(99.8 %id)
BU170038 embryonal carcinoma, cell line, testis .a 1745 to 2536 1 to 799       799/904
(88 %)
22 diff
(97.6 %id)
BX475893   .a 1862 to 2512 1 to 651       651/651
(100 %)
0 diff
(100 %id)
AK123612 tongue, tumor tissue .a 1901 to 6666 1 to 4766   tiling clone, available from FLJ,   4766/4766
(100 %)
2 diff
(100.0 %id)
DA458047 tongue, tumor tissue .a 1902 to 2488 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
CX164170 human embryonic stem cells differentiated toan early endodermal cell type .a 2045 to 2859 1 to 815       815/815
(100 %)
0 diff
(100 %id)
DA759473   .a 2212 to 2687 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
CN306253 embryonic stem cells, cell lines H1, H7, andH9 .a 2541 to 3195 1 to 655       655/655
(100 %)
0 diff
(100 %id)
AW631010 2 pooled high-grade transitional celltumors, genitourinary tract .a 2673 to 3118 1 to 446       446/446
(100 %)
1 diff
(99.8 %id)
BX538335 human rectum tumor .a 2700 to 6667 1 to 3968   tiling clone, available from DKFZ, AAA   3968/3968
(100 %)
5 diff
(99.9 %id)
CN306254 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2813 to 3274 1 to 462       462/462
(100 %)
0 diff
(100 %id)
BU152945 embryonal carcinoma, cell line, testis .a 2872 to 3697 1 to 846   tiling clone,   846/945
(89 %)
22 diff
(97.7 %id)
BM558681 duodenal adenocarcinoma, cell line, small intestine .a 3103 to 3888 1 to 786       786/991
(79 %)
3 diff
(99.7 %id)
CD643679 Embryonic Stem cells .a 3141 to 3879 12 to 748       737/825
(89 %)
6 diff
(99.3 %id)
CV374805 head_neck .a 3459 to 3915 39 to 495       457/495
(92 %)
6 diff
(98.8 %id)
AK074727   .a 3509 to 6666 1 to 3159   available from FLJ,   3159/3159
(100 %)
7 diff
(99.8 %id)
DA728470   .a 3510 to 4270 2 to 765   capped   764/764
(100 %)
8 diff
(99.0 %id)
AK315750 uterus .a 3689 to 5733 1 to 2045       2045/2045
(100 %)
2 diff
(100.0 %id)
BC033209 Muscle, rhabdomyosarcoma .a 3959 to 6665 1 to 2707   available from MGC, AAA   2707/2707
(100 %)
2 diff
(100.0 %id)
BI084363 epidermoid carcinoma, cell line, salivary gland .a 5061 to 5795 1 to 739       739/739
(100 %)
14 diff
(98.2 %id)
BU180552 epidermoid carcinoma, cell line, salivary gland .a 5063 to 5920 1 to 863       863/977
(88 %)
8 diff
(99.2 %id)
BU146324 epidermoid carcinoma, cell line, salivary gland .a 5063 to 5878 1 to 822       822/905
(90 %)
19 diff
(98.0 %id)
BQ674190 epidermoid carcinoma, cell line, salivary gland .a 5063 to 5823 1 to 772       772/961
(80 %)
32 diff
(96.7 %id)
CN390036 embryonic stem cells, cell lines H1, H7, andH9 .a 5067 to 5669 1 to 604       604/604
(100 %)
2 diff
(99.7 %id)
BE797787 lung, small cell carcinoma .a 5088 to 5830 1 to 750   available from MGC,   750/765
(98 %)
29 diff
(96.3 %id)
U75822   .a 5414 to 5546 136 to 3       134/137
(97 %)
0 diff
(100 %id)
BM794383 Ascites, stomach .a 5752 to 6279 1 to 528       528/528
(100 %)
0 diff
(100 %id)
H70297 liver and spleen .a 5770 to 6206 1 to 445       445/448
(99 %)
11 diff
(97.6 %id)
BI084688 epidermoid carcinoma, cell line, salivary gland .a 5918 to 6594 700 to 23       678/701
(96 %)
0 diff
(100 %id)
DB314450 tongue, tumor tissue .a 6106 to 6666 561 to 1       561/561
(100 %)
0 diff
(100 %id)
AW627706 2 pooled high-grade transitional celltumors, genitourinary tract .a 6418 to 6667 269 to 22   tiling clone, AAA   248/248
(100 %)
12 diff
(95.2 %id)
GQ227787   .b 1 to 6656 1 to 6656 S1008G V1372I tiling clone,   6656/6656
(100 %)
3 diff
(100.0 %id)
BE719503 head_neck .b 5800 to 6362 1 to 562       562/565
(99 %)
17 diff
(97.0 %id)
CD637651   .b 5886 to 6377 500 to 9       492/507
(97 %)
0 diff
(100 %id)
CD637652   .b 5886 to 6377 8 to 499       492/510
(96 %)
4 diff
(99.3 %id)
BI044475 ovary .b 5958 to 6270 10 to 321       312/321
(97 %)
6 diff
(98.2 %id)
BI039090 nervous_tumor .b 6017 to 6179 163 to 1       163/163
(100 %)
0 diff
(100 %id)
BU634280 cell lines, Chondrosarcoma .b 6034 to 6661 648 to 19   AAA   630/630
(100 %)
2 diff
(99.7 %id)
CN390037 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 6043 to 6627 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BX089227 heart .b 6075 to 6546 1 to 472       472/472
(100 %)
0 diff
(100 %id)
BG034259 breast, mammary adenocarcinoma, cell line .b 6123 to 6892 1 to 784   tiling clone,   784/1012
(77 %)
47 diff
(95.4 %id)
AI638593 pooled germ cell tumors .b 6193 to 6662 482 to 13   AAA   470/470
(100 %)
1 diff
(99.8 %id)
AI240212 pooled .b 6226 to 6665 440 to 1       440/440
(100 %)
1 diff
(99.8 %id)
AA970846 pooled .b 6249 to 6664 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
AI991616 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 6253 to 6661 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
FN071695 breast carcinoma .b 6278 to 6370 1 to 95       95/95
(100 %)
2 diff
(97.9 %id)
AA831004 germinal center B cell .b 6299 to 6662 397 to 34   AAA   364/364
(100 %)
1 diff
(99.8 %id)
AI092801 heart .b 6322 to 6663 370 to 29   AAA   342/342
(100 %)
8 diff
(97.7 %id)
AA682401 liver and spleen .b 6349 to 6663 339 to 25   AAA   315/315
(100 %)
0 diff
(100 %id)
AW087795 pooled .b 6473 to 6667 211 to 17       195/211
(92 %)
0 diff
(100 %id)
AA659039 alveolar rhabdomyosarcoma .b 6620 to 6736 1 to 117   tiling clone,   117/120
(97 %)
3 diff
(97.5 %id)
BX097471 colon, moderately-differentiated adenocarcinoma .b 6830 to 7290 13 to 473   tiling clone,   461/473
(97 %)
0 diff
(100 %id)
CN390035 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c-u 1 to 723 3 to 725   tiling clone,   725/725
(100 %)
0 diff
(100 %id)
DB254986 uterus .c-u 1 to 563 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BG828090 muscle, rhabdomyosarcoma .c-u 269 to 1050 1 to 781   available from MGC,   781/781
(100 %)
9 diff
(98.9 %id)
TI_59391852   .c-u 274 to 991 129 to 846   tiling clone,   718/718
(100 %)
1 diff
(99.9 %id)
BM013907 breast, mammary adenocarcinoma, cell line .c-u 275 to 991 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
BF896392 marrow .c-u 584 to 878 308 to 5   tiling clone, Submitted on the opposite strand 304/308
(98 %)
0 diff
(100 %id)
CN390038 embryonic stem cells, DMSO-treated H9 cellline .c-u 695 to 1185 9 to 499       491/499
(98 %)
6 diff
(98.8 %id)
BI253709 cervical carcinoma cell line, cervix .c-u 738 to 1295 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
BQ053887 blood, natural killer cells, cell line .c-u 798 to 1643 1 to 858   tiling clone,   858/1113
(77 %)
32 diff
(97.2 %id)
CX759692 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c-u 892 to 1635 1 to 739     Submitted on the opposite strand 739/812
(91 %)
8 diff
(99.1 %id)
BE786987 large cell carcinoma, lung .c-u 1062 to 1782 1 to 726   tiling clone,   726/939
(77 %)
31 diff
(96.7 %id)
AI380968 B-cell, chronic lymphotic leukemia .c-u 1208 to 1517 13 to 322     Submitted on the opposite strand 310/322
(96 %)
6 diff
(98.2 %id)
BI062286 uterus_tumor .c-u 1388 to 1897 510 to 1   tiling clone,   510/510
(100 %)
1 diff
(99.9 %id)
BC002881 Lung, small cell carcinoma .d 1 to 2366 1 to 2368 exact tiling clone, available from MGC, AAA   2368/2368
(100 %)
3 diff
(99.9 %id)
BM800669 leiomyosarcoma, uterus .d 724 to 1613 1 to 895       895/1061
(84 %)
28 diff
(97.4 %id)
BG994531 head_neck .d 1068 to 1634 1 to 569       569/569
(100 %)
49 diff
(91.4 %id)
BM853213 Ascites, stomach .d 1339 to 1865 1 to 530   tiling clone,   530/530
(100 %)
38 diff
(92.9 %id)
BX279805 pooled germ cell tumors .d 1825 to 2189 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
AI961106 pooled germ cell tumors .d 1829 to 2357 527 to 1   tiling clone,   527/527
(100 %)
4 diff
(99.3 %id)
CF597118 ovary .e-u 1 to 741 1 to 741 exact tiling clone,   741/743
(99 %)
5 diff
(99.4 %id)
BM724339 eye, fetal eye Gene C15orf42, variant not shown         This clone was ignored    
BU741617 eye, fetal eye Gene C15orf42, variant not shown       AAA This clone was ignored    
DB135523 thymus Gene C15orf42, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB344960 thymus Gene C15orf42, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C